MIL
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
Dividend
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Medico Intercont. do?
Medico Intercontinental was incorporated on August 14, 1984. The company is into the business of trading of Pharmaceutical Products. It is providing a platform to all research based biopharmaceuticals companies reaching their Novel and innovative therapies to every part of the globe.
Who are the competitors of Medico Intercont.?
Medico Intercont. major competitors are Neeraj Paper Market., Mono Pharmacare, Davin Sons Retail, Shubhlaxmi Jewel Art, Dipna Pharma., Shree Metalloys, Maharashtra Corpn.. Market Cap of Medico Intercont. is ₹23 Crs. While the median market cap of its peers are ₹22 Crs.
Is Medico Intercont. financially stable compared to its competitors?
Medico Intercont. seems to be less financially stable compared to its competitors. Altman Z score of Medico Intercont. is 3.5 and is ranked 4 out of its 8 competitors.
Does Medico Intercont. pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Medico Intercont. latest dividend payout ratio is 2.77% and 3yr average dividend payout ratio is 2.77%
How has Medico Intercont. allocated its funds?
Companies resources are allocated to majorly unproductive assets like Accounts Receivable, Short Term Loans & Advances
How strong is Medico Intercont. balance sheet?
Balance sheet of Medico Intercont. is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Medico Intercont. improving?
The profit is oscillating. The profit of Medico Intercont. is -₹7.57 Crs for TTM, ₹5.06 Crs for Mar 2025 and ₹3.95 Crs for Mar 2024.
Is the debt of Medico Intercont. increasing or decreasing?
Yes, The net debt of Medico Intercont. is increasing. Latest net debt of Medico Intercont. is ₹61.14 Crs as of Sep-25. This is greater than Mar-25 when it was ₹11.92 Crs.
Is Medico Intercont. stock expensive?
Medico Intercont. is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Medico Intercont. is 9.98, while 3 year average PE is 128. Also latest EV/EBITDA of Medico Intercont. is 24.99 while 3yr average is 11.06.
Has the share price of Medico Intercont. grown faster than its competition?
Medico Intercont. has given lower returns compared to its competitors. Medico Intercont. has grown at ~-38.64% over the last 1yrs while peers have grown at a median rate of 3.67%
Is the promoter bullish about Medico Intercont.?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Medico Intercont. is 57.15% and last quarter promoter holding is 57.15%.
Are mutual funds buying/selling Medico Intercont.?
There is Insufficient data to gauge this.